ORIGINAL ARTICLE
Lowered expression level of INSC predicts poor prognosis in patients with colon cancer
1
Molecular Biology Laboratory, Chongqing Medical and Pharmaceutical College, Chongqing, China
2
Department of Pathology, People’s Hospital of Chongqing LiangJiang New Area, Chongqing, China
Submission date: 2023-05-10
Acceptance date: 2023-05-30
Publication date: 2023-07-10
Pol J Pathol 2023;74(2):109-121
KEYWORDS
TOPICS
ABSTRACT
The aim of this study was to investigate the prognostic value of inscuteable spindle orientation adaptor protein (INSC) in colon cancer (CC).
Firstly, transcriptional change of INSC was analysed using the data from public databases. Next, INSC protein expression was assessed by immunohistochemistry. Its correlation with clinicopathological features and the prognostic values of patients were also investigated. Then, an INSC-based nomogram was built to predict CC prognosis.
Compared to normal tissues, INSC was significantly downregulated at the transcriptional level in CC tissues. A low INSC mRNA level not only positively correlated with TNM stage (tumour-nodus-metastases), advanced T stage, and N stage, but also with the shorter 5- and 8-year overall survival (OS) and disease-specific survival. Concerning protein level, INSC downregulation was confirmed in CC samples. In terms of the correlation with N stage and 5- and 8-year OS, it was also consistent with mRNA levels. Cox regression analysis indicated that INSC protein expression was an independent prognostic factor for OS. The nomogram showed better prognostic accuracy and clinical net benefit for 5-year OS than TNM staging.
Altogether, downregulation of INSC is related to inferior clinicopathological features and patient outcomes, and it may be a novel independent prognostic biomarker in CC.
Firstly, transcriptional change of INSC was analysed using the data from public databases. Next, INSC protein expression was assessed by immunohistochemistry. Its correlation with clinicopathological features and the prognostic values of patients were also investigated. Then, an INSC-based nomogram was built to predict CC prognosis.
Compared to normal tissues, INSC was significantly downregulated at the transcriptional level in CC tissues. A low INSC mRNA level not only positively correlated with TNM stage (tumour-nodus-metastases), advanced T stage, and N stage, but also with the shorter 5- and 8-year overall survival (OS) and disease-specific survival. Concerning protein level, INSC downregulation was confirmed in CC samples. In terms of the correlation with N stage and 5- and 8-year OS, it was also consistent with mRNA levels. Cox regression analysis indicated that INSC protein expression was an independent prognostic factor for OS. The nomogram showed better prognostic accuracy and clinical net benefit for 5-year OS than TNM staging.
Altogether, downregulation of INSC is related to inferior clinicopathological features and patient outcomes, and it may be a novel independent prognostic biomarker in CC.
REFERENCES (36)
1.
Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin 2020; 70: 145-164.
2.
Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut 2019; 68: 1450-1457.
3.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70: 7-30.
4.
Costantini L, Molinari R, Farinon B, Merendino N. Retinoic acids in the treatment of most lethal solid cancers. J Clin Med 2020; 9: 360.
5.
Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 2019; 5: 1749-1768.
6.
Perna C, Navarro A, Ruz-Caracuel I, et al. Molecular heterogeneity of high grade colorectal adenocarcinoma. Cancers 2021; 13: 233.
7.
Mayo E, Llanos AA, Yi X, et al. Prognostic value of tumour deposit and perineural invasion status in colorectal cancer patients: a SEER-based population study. Histopathology 2016; 69: 230-238.
8.
Al-Sukhni E, Attwood K, Gabriel EM, et al. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: a retrospective cohort study. Int J Surg 2017; 37: 42-49.
9.
Allegra CJ, Rumble RB, Hamilton SR, et al. Extended RAS gene mutation testing in metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015. J Clin Oncol 2016; 34: 179-185.
10.
Santini D, Spoto C, Loupakis F, et al. High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice. Ann Oncol 2010; 21: 1565.
11.
Valtorta E, Martino C, Sartore-Bianchi A, et al. Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. Mod Pathol 2015; 28: 1481-1491.
12.
Punt CJ, Koopman M, Vermeulen L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat Rev Clin Oncol 2017; 14: 235-246.
13.
Weiser MR, Gonen M, Chou JF, et al. Predicting survival after curative colectomy for cancer: individualizing colon cancer staging. J Clin Oncol 2011; 29: 4796-4802.
14.
Rejon C, Al-Masri M, McCaffrey L. Cell polarity proteins in breast cancer progression. J Cell Biochem 2016; 117: 2215-2223.
15.
Knoblich JA. Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol Cell Biol 2010; 11: 849-860.
16.
Ellenbroek SI, Iden S, Collard JG. Cell polarity proteins and cancer. Semin Cancer Biol 2012; 22: 208-215.
17.
Kraut R, Campos-Ortega JA. INSCuteable, a neural precursor gene of Drosophila, encodes a candidate for a cytoskeleton adaptor protein. Dev Biol 1996; 174: 65-81.
18.
Siller KH, Doe CQ. Spindle orientation during asymmetric cell division. Nat Cell Biol 2009; 11: 365-374.
19.
Postiglione MP, Juschke C, Xie Y, et al. Mouse INSCuteable induces apical-basal spindle orientation to facilitate intermediate progenitor generation in the developing neocortex. Neuron 2011; 72: 269-284.
20.
Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 2005; 437: 275-280.
21.
Kwon Y, Park M, Jang M, et al. Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype. Oncotarget 2017; 8: 39367-39381.
22.
Sole X, Crous-Bou M, Cordero D, et al. Discovery and validation of new potential biomarkers for early detection of colon cancer. PLoS One 2014; 9: e106748.
23.
Khamas A, Ishikawa T, Shimokawa K, et al. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2’- deoxycytidine, microarray and gene expression profile. Cancer Genom Proteom 2012; 9: 67-75.
24.
Han X, Tang J, Chen T, et al. Restoration of GATA4 expression impedes breast cancer progression by transcriptional repression of ReLA and inhibition of NF-kappaB signaling. J Cell Biochem 2019; 120: 917-927.
25.
Yuzawa S, Kamakura S, Iwakiri Y, et al. Structural basis for interaction between the conserved cell polarity proteins INSCuteable and Leu-Gly-Asn repeat-enriched protein (LGN). Proc Natl Acad Sci U S A 2011; 108: 19210-19215.
26.
Kraut R, Chia W, Jan LY, et al. Role of INSCuteable in orienting asymmetric cell divisions in Drosophila. Nature 1996; 383: 50-55.
27.
Siegrist SE, Doe CQ. Microtubule-induced Pins/Galphai cortical polarity in Drosophila neuroblasts. Cell 2005; 123: 1323-1335.
28.
Mauser JF, Prehoda KE. INSCuteable regulates the Pins-Mud spindle orientation pathway. PLoS One 2012; 7: e29611.
29.
Ishibashi R, Kozuki S, Kamakura S, et al. c-Rel regulates INSCuteable gene expression during mouse embryonic stem cell differentiation. J Biol Chem 2016; 297: 3333-3345.
30.
Zigman M, Cayouette M, Charalambous C, et al. Mammalian INSCuteable regulates spindle orientation and cell fate in the developing retina. Neuron 2005; 48: 539-545.
31.
Zheng Z, Wan Q, Liu J, et al. Evidence for dynein and astral microtubule-mediated cortical release and transport of Galphai/LGN/NuMA complex in mitotic cells. Mol Biol Cell 2013; 24: 901-913.
32.
Kamakura S, Nomura M, Hayase J, et al. The cell polarity protein mINSC regulates neutrophil chemotaxis via a noncanonical G protein signaling pathway. Dev Cell 2013; 26: 292-302.
33.
Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2011; 12: 23-38.
34.
An H, Ge W, Xi Y, et al. INSCuteable maintains type I neuroblast lineage identity via Numb/Notch signaling in the Drosophila larval brain. J Genet Genomics 2017; 44: 151-162.
35.
Flores AN, McDermott N, Meunier A, et al. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nat Rev Urol 2014; 11: 499-507.
36.
Man J, Yu X, Huang H, et al. Hypoxic induction of vasorin regulates notch1 turnover to maintain glioma stem-like cells. Cell Stem Cell 2018; 22: 104-118 e106.
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
